About 12% of Americans aged 14 to 49 have genital herpes caused by HSV-2, the virus most commonly responsible for the condition. That translates to roughly one in eight people in that age range. Globally, an estimated 520 million people aged 15 to 49 (about 13%) carry HSV-2. The true number of genital herpes cases is likely higher, because HSV-1, traditionally associated with oral cold sores, increasingly causes genital infections as well.
U.S. Prevalence by the Numbers
The most recent nationally representative data from the CDC, covering 2015 to 2016, puts HSV-2 prevalence at 12.1% among people aged 14 to 49. That figure has actually been falling steadily: in 1999 to 2000, it was 18.0%. So prevalence dropped by nearly 6 percentage points over roughly 17 years, a decline seen across all racial and ethnic groups surveyed.
These numbers come from blood tests that detect antibodies to HSV-2, regardless of whether the person has ever had symptoms. They capture both people who know they carry the virus and the much larger group who have no idea.
Rates Vary by Race and Ethnicity
HSV-2 does not affect all populations equally. In the 2015 to 2016 survey, prevalence among non-Hispanic Black Americans was 34.6%, compared to 9.4% among Mexican Americans and 8.1% among non-Hispanic white Americans. All three groups saw meaningful declines from the late 1990s, when rates were 41.5%, 12.8%, and 14.1% respectively. These disparities reflect differences in sexual network patterns and access to sexual health resources rather than any biological susceptibility.
Women Are Affected More Than Men
HSV-2 prevalence is consistently higher in women than in men. The virus transmits more easily from men to women during vaginal sex because of the larger surface area of mucosal tissue exposed. This biological difference means that across every age group and demographic, women carry a disproportionate share of infections.
Most People Don’t Know They Have It
This is the statistic that surprises most people: more than 80% of those with HSV-2 infections either have no symptoms, have symptoms too mild to notice, or get misdiagnosed because they never develop the classic genital sores. Someone might experience occasional irritation, a small bump mistaken for an ingrown hair, or nothing at all. The result is that the vast majority of people with genital herpes are completely unaware of their status.
Even without visible symptoms, the virus can still be transmitted. Research from the University of Washington found that people with genital herpes shed virus on roughly 7 to 12% of days, even when they feel fine and have no sores present. Shedding rates tend to be higher in the first year after infection and decline somewhat over time, but the virus can reactivate unpredictably on any given day.
Why Routine Testing Isn’t Recommended
Given how common the virus is, you might wonder why herpes isn’t part of standard STI screening panels. The U.S. Preventive Services Task Force actively recommends against routine blood testing for herpes in people without symptoms, giving it a “D” grade, meaning the harms outweigh the benefits.
The main problem is the blood tests themselves. The widely available antibody tests have a high rate of false positives when used on people with no symptoms, which means a screening program would incorrectly tell many people they have herpes when they don’t. A false positive for a stigmatized infection carries real psychological harm. On the other hand, for people who do test truly positive but have never had symptoms, the medical benefit of knowing is unclear since there’s no strong rationale for treating someone who isn’t experiencing outbreaks.
This recommendation does not apply if you have symptoms suggestive of herpes, a partner with a known infection, or HIV. In those situations, testing is appropriate and your clinician can order it.
The HSV-1 Factor
The 12% figure only counts HSV-2. An increasing share of new genital herpes cases are caused by HSV-1, the same virus behind oral cold sores. This happens primarily through oral sex. As fewer young people acquire HSV-1 during childhood (which would give them some cross-protection), they become vulnerable to catching it genitally as adults. Adding HSV-1 genital cases to the count would push the true prevalence of genital herpes noticeably above 12%, though precise combined figures are hard to pin down because most HSV-1 blood tests can’t distinguish between oral and genital infections.
One practical difference: genital HSV-1 tends to cause fewer and less severe recurrences than genital HSV-2. Viral shedding also decreases more sharply over time. So while both viruses cause genital herpes, HSV-1 infections in the genital area are generally milder in the long run.
Prevalence Worldwide
The World Health Organization estimates that 520 million people aged 15 to 49 were living with HSV-2 in 2020, representing about 13% of the global population in that age range. Rates vary enormously by region. Sub-Saharan Africa has the highest prevalence, with some countries exceeding 30 to 40% of the adult population. Parts of Europe and East Asia tend to have lower rates, often in the single digits. The U.S. sits roughly in the middle of the global range.
These regional differences are shaped by factors including average age of sexual debut, number of lifetime sexual partners, condom use, circumcision rates, and the prevalence of other STIs that create breaks in the skin and make transmission easier.
The Trend Is Downward
If there’s encouraging news in the data, it’s that HSV-2 prevalence has been declining in the U.S. for nearly two decades. The drop from 18% to 12% between 1999 and 2016 occurred across all racial, ethnic, and gender groups. Researchers attribute this partly to increased condom use and broader sexual health awareness, though no single explanation fully accounts for the decline. The virus remains extremely common, but the trajectory is moving in the right direction.